封面
市場調查報告書
商品編碼
2008126

缺血性介入神經放射學醫療設備市場:按器材類型、手術類型、最終用戶和地區分類

Ischemic Neurological Interventional Medical Devices Market, By Device type, By Procedure type, By End user, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年,缺血性介入神經放射學醫療設備市場規模估計為27.647億美元,預計2033年將達到40.502億美元。預計2026年至2033年,該市場將以5.6%的複合年成長率成長。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 27.647億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 5.60% 預計金額(2033 年) 40.502億美元

醫療設備是指用於緩解、治療、診斷、預防或治癒疾病的裝置、機器、儀器、設備、外用試劑或類似產品,其目的是對人體或其內部產生物理、結構或機械作用。醫療設備的審查是基於其對病人的風險,高風險產品需要比低風險產品更多的臨床證據。美國食品藥物管理局(FDA) 負責審查醫療設備,並僅核准符合要求的產品。依據風險程度,醫療設備分為三類:I 類、II 類和 III 類。

缺血性中風,也稱為腦缺血,是指大腦某部分的血液供應中斷,導致腦組織無法獲得氧氣和營養。缺血性中風有多種類型,包括出血性中風和短暫性腦缺血發作(TIA)。目前採用多種介入神經放射學干預措施,透過機械取栓術清除血栓並重新開通阻塞的血管,以恢復受影響區域的腦部功能。

市場動態

缺血性中風發病率的不斷上升預計將成為推動全球缺血性介入神經放射學醫療設備市場在預測期內成長的主要因素。缺血性中風發生率的上升也是推動神經系統醫療設備和儀器需求成長的主要因素之一。例如,根據世界卒中組織(WSO)2022年1月發布的數據,卒中是第二大死因,其中70%為缺血性卒中,143.0%的卒中病例導致失能調整後存活年(DALYs)損失。

本報告的主要特點

  • 本報告指出了各個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 我們根據以下參數介紹主要企業的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
  • 《全球缺血性介入神經放射學醫療設備市場》報告面向該行業的各種相關人員,包括經銷商、供應商、產品製造商、分銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球缺血性介入神經放射學醫療設備市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 近期趨勢
  • 收購與合作趨勢
  • 法規環境
  • PEST分析

第4章:全球缺血性介入神經放射學醫療設備市場:依器材類型分類(2026-2033 年)

  • 概述
  • 神經血栓除去裝置
  • 栓塞支架
  • 支架系統

第5章:缺血性介入神經放射學醫療設備全球市場:依手術類型分類(2026-2033 年)

  • 概述
  • 機械血栓切除術
  • 頸動脈切除術
  • 支架置入

第6章:缺血性介入神經放射學醫療設備全球市場:依最終用戶分類(2026-2033 年)

  • 概述
  • 醫院
  • 專科診所
  • 門診手術中心

第7章 全球缺血性介入神經放射學醫療設備市場:按地區分類(2026-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 中非
    • 北非

第8章 競爭情勢

  • Stryker
  • Johnson &Johnson Services, Inc.
  • Penumbra, Inc.
  • Medtronic
  • VESALIO, LLC.
  • Sense Neuro
  • 880 Medical, LLC.
  • Terumo Corporation.
  • Imperative Care.
  • WL Gore &Associate, Inc.
  • MicroPort Scientific Corporation.
  • KANEKA CORPORATION.
  • Integer Holdings Corporation.
  • Wallaby Medical.

第9章

  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI5330

Ischemic Neurological Interventional Medical Devices Market is estimated to be valued at USD 2,764.7 Mn in 2026 and is expected to reach USD 4,050.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2,764.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.60% 2033 Value Projection: USD 4,050.2 Mn

Medical device is an apparatus, machine, tool, instrument, in vitro reagent, or similar the product that mitigate, treat, diagnose, prevent, cure a disease and its purpose is to achieve physical, structural and mechanical action with or within the body. Medical devices are reviewed according to the risk to the patient, where higher risk products require more clinical evidence than those of lower risk products. The U.S. Food and Drug Administration (FDA) reviews medical technology devices and approve only those products which have met the requirements. There are three different categories of medical devices base on the risk. They are basically class I, class II and class III.

Ischemic stroke is also referred as cerebral ischemia. It occurs when the blood supply is interrupted in some part of brain and which will prevents brain tissues from getting oxygen and nutrients. There are different types of ischemic strokes like hemorrhagic stroke, transient ischemic attack, etc. Different Neuro-interventional methods are used to open the blocked blood vessel by removing the clot with help of mechanical thrombectomy, so that that part of brain is restored.

Market Dynamics

Increasing incidence of Ischemic stroke are the major factors that are expected to drive growth of the global ischemic neurological interventional medical devices market over the forecast period. Increasing incidence of Ischemic stroke is also one of the major factors driving demand for neurological medical devices and tools. For instance, in January 2022, according to data published by World Stroke Organization (WSO), stroke is second leading cause of death, out of that 70% people had ischemic stroke and 143.0% had disability-adjusted life-years lost (DALYs).

Key features of the study

  • This report provides an in-depth analysis of the global ischemic neurological interventional medical devices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Stryker, Johnson & Johnson Services Inc., Penumbra, Inc. Medtronic, VESALIO,LLC., Sense Neuro, 880 Medical, LLC., Terumo Corporation., Imperative Care., W. L. Gore & Associate, Inc. , MicroPort Scientific Corporation., KANEKA CORPORATION., Integer Holdings Corporation., Wallaby Medical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global ischemic neurological interventional medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ischemic neurological Interventional medical devices market

Market Segmentation

  • Global Ischemic Neurological Interventional Medical Devices Market, By Device Type
    • Neurothrombectomy Devices
    • Aspiration/Suction Catheters
    • Clot Retrievers
    • Snare-like devices
    • Others (Lasers etc.)
    • Embolization Stents
    • Stenting System
  • Global Ischemic Neurological Interventional Medical Devices Market, By Procedure Type
    • Mechanical Thrombectomy
    • Carotid Endarterectomy
    • Stenting
  • Global Ischemic Neurological Interventional Medical Devices Market, By End User
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
  • Global Ischemic Neurological Interventional Medical Devices Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Global ischemic neurological interventional medical devices market: Key Players
    • Stryker
    • Johnson & Johnson Private Limited.
    • Penumbra, Inc.
    • Medtronic
    • VESALIO, LLC.
    • Sense Neuro
    • 880 Medical, LLC.
    • Terumo Corporation.
    • Imperative Care.
    • W.L. Gore & Associate, Inc.
    • MicroPort Scientific Corporation.
    • KANEKA CORPORATION.
    • Integer Holdings Corporation.
    • Wallaby Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Device Type
    • Market Snapshot, By Procedure Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Regulatory Scenario
  • PEST Analysis

4. Global Ischemic Neurological Interventional Medical Devices Market, By Device Type, 2026 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Neurothrombectomy Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
      • Aspiration/Suction Catheters
      • Clot Retrievers
      • Snare-like devices
      • Others (Lasers, etc.)
  • Embolization Stents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Stenting System
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Ischemic Neurological Interventional Medical Devices Market, By Procedure Type, 2026 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Mechanical Thrombectomy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Carotid Endarterectomy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Stenting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Ischemic Neurological Interventional Medical Devices Market, By End User, 2026 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Specialty Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Ischemic Neurological Interventional Medical Devices Market, By Region, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
  • North America
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • South Africa
      • Central Africa
      • North Africa

8. Competitive Landscape

  • Stryker
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Johnson & Johnson Services, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Penumbra, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Medtronic
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • VESALIO, LLC.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Sense Neuro
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • 880 Medical, LLC.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Terumo Corporation.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Imperative Care.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • W. L. Gore & Associate, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • MicroPort Scientific Corporation.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • KANEKA CORPORATION.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Integer Holdings Corporation.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Wallaby Medical.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us